Profilo
Stephen Lichaw is currently the Vice President-Business Development at Lirum Therapeutics, Inc. He previously worked as a Managing Director at Middlebury Securities LLC and as a Principal at Ladenburg Thalmann & Co., Inc. Mr. Lichaw holds an MBA from Cornell University and an undergraduate degree from the University of Hartford.
Posizioni attive di Stephen Lichaw
| Società | Posizione | Inizio |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2022 |
Precedenti posizioni note di Stephen Lichaw
| Società | Posizione | Fine |
|---|---|---|
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | - |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Investitore di Private Equity | - |
Formazione di Stephen Lichaw
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Finance |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
















